Rituximab in the treatment of refractory lupus nephritis with vasculitis
Dysfunction of the B lymphocyte, an important component of adaptive immunity, is thought to be important in the pathogenesis of lupus nephritis (LN). There are several novel strategies emerging including B-cell depletion by the monoclonal antibodies to B-cell markers, rituximab. We describe an unusu...
Main Authors: | Huseyin Kadikoy, Waqar Haque, Salman Ahmed, Abdul Abdellatif |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2012-01-01
|
Series: | Saudi Journal of Kidney Diseases and Transplantation |
Online Access: | http://www.sjkdt.org/article.asp?issn=1319-2442;year=2012;volume=23;issue=2;spage=334;epage=337;aulast=Kadikoy |
Similar Items
-
Posterior reversible encephalopathy syndrome in a patient with lupus nephritis
by: Huseyin Kadikoy, et al.
Published: (2012-01-01) -
Rituximab for treatment of severe lupus nephritis
by: Baskin E, et al.
Published: (2008-09-01) -
Lupus nephritis, pregnancy and rituximab
by: Enrique Dorado, et al.
Published: (2017-04-01) -
Lupus Nephritis: Experience of Treatment with Rituximab (Clinical Observation)
by: D.D. Ivanov, et al.
Published: (2012-05-01) -
USE OF RITUXIMAB IN PATIENTS WITH LUPUS NEPHRITIS
by: Anna Vasilyevna Torgashina, et al.
Published: (2010-08-01)